Shelley Chu

Shelley Chu

Direttore/Membro del Consiglio presso ODYSSEY THERAPEUTICS, INC.

Patrimonio netto: 207 887 $ in data 30/06/2026

56 anni
Health Technology
Finance
Commercial Services

Profilo

Shelley Chu is currently an Independent Director at Odyssey Therapeutics, Inc. since 2025.
Current roles also include Director positions at Alpha-9 Oncology, Inc., Diagonal Therapeutics, Inc., Zag Bio, Inc., SFJ Pharmaceuticals, Inc., Antares Therapeutics, Inc., 3T Biosciences, Inc., ImmunOs Therapeutics AG, Adanate, Inc., Q32 Bio Operations, Inc., Protego Biopharma, Inc., IFM Cinque, Inc., IFM Continua, Inc., IFM Quattro, Inc., TRIANA Biomedicines, Inc., Medikine, Inc., Trishula Therapeutics, Inc., Enlaza Therapeutics, Inc., Ifm Therapeutics, Inc., Abata Therapeutics, Inc., IFM Due, Inc., and Seismic Therapeutic, Inc. since 2022.
A Partner at Lightspeed Management Co LLC since 2020.
Former roles include Director at Kalidex Pharmaceuticals, Inc., Venatorx Pharmaceuticals, Inc., Scorpion Therapeutics, Inc., Tizona Therapeutics, Inc., Phathom Pharmaceuticals, Inc., Novartis Inflammasome Research, Inc., and Partner at Abingworth LLP and Abingworth Management, Inc. Senior Director-R&D Strategy at Gilead Pharmasset LLC from 2012 to 2015.
Independent Director at HilleVax, Inc. from 2021 to 2025.
Principal at Frazier Management LLC and Flagship Pioneering, Inc. from 2002 to 2005.
Education includes undergraduate studies at Princeton University and a doctorate from The University of California, San Francisco.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
11/05/2026 11.111 ( 0,02% ) 207 887 $ 30/06/2026

Posizioni attive di Shelley Chu

SocietàPosizioneInizio
ODYSSEY THERAPEUTICS, INC. Direttore/Membro del Consiglio 01/08/2025
Direttore/Membro del Consiglio 10/02/2022
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -

Precedenti posizioni note di Shelley Chu

SocietàPosizioneFine
HILLEVAX, INC. Direttore/Membro del Consiglio 17/09/2025
░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ -
Vedi nel dettaglio l'esperienza di Shelley Chu

Formazione di Shelley Chu

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

40

Relazioni di 1° grado

34

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private34

Finance

Health Technology

Health Technology

Finance

Finance

Finance

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

  1. Mercati
  2. Insiders
  3. Shelley Chu